The Coronavirus Vaccine Market is expected to grow at a -12.0 % CAGR during the forecast period for 2024-2034. Coronavirus Disease (COVID-19) is caused by coronavirus. Coronavirus is a type of virus which causes respiratory illness in humans and can causes serious illness in geriatric population (Mainly those with diabetes, chronic respiratory disease, cardiovascular disease, and cancer). Out of the seven types of coronavirus, SARS-CoV-2 is th...
Report ID: 1019 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 185
Global Idiopathic Pulmonary Fibrosis Management Market Size is valued at USD 3,113.5 Mn in 2023 and is predicted to reach USD 3,429.6 Mn by the year 2031 at a 1.28% CAGR during the forecast period for 2024 to 2031. Idiopathic Pulmonary Fibrosis Management Market Size, Share & Trends Analysis Report By Drug Class (Pirfenidone, Nintedanib, Interferon Gammato1b, Others), By Treatment (Oxygen Therapy, Lung Transplant), By Route of Administration...
Report ID: 2885 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 165
The Global Softwall Cleanrooms Market Size is predicted to record at a 5.24% CAGR during the forecast period for 2023-2031. Manufacturing requirements for semiconductors, medical devices, and other products are cleaned in softwall cleanrooms. The need for cleanrooms rises as a result of the control they offer over environmental factors like temperature and the possibility of particle entry. A regulated environment where product contamination i...
Report ID: 1784 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Sprycel Market Size is valued at USD 5.47 Bn in 2022 and is predicted to reach USD 8.52 Bn by the year 2031 at a 5.2% CAGR during the forecast period for 2023-2031. One of the effective cancer drugs is Sprycel. Adults with some significant forms of leukaemia (cancer of the white blood cells) are treated with it. Adult patients should use SPRYCEL® (dasatinib) for therapy. Newly discovered chronic myeloid leukaemia (CML) in the chronic p...
Report ID: 2041 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Clinical Trial Biorepository & Archiving Solutions Market Size is valued at USD 4.24 Bn in 2023 and is predicted to reach USD 8.49 Bn by the year 2031 at an 9.12% CAGR during the forecast period for 2024-2031. Clinical trial biorepositories and archiving solutions play pivotal roles in the pharmaceutical and biomedical research sectors by providing specialized facilities and ...
Report ID: 2553 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
Global CIN And HR-HPV Treatment Market Size is valued at USD 11.48 billion in 2022 and is predicted to reach USD 20.08 billion by the year 2031 at a 6.5% CAGR during the forecast period for 2023-2031. CIN and HR-HPV treatment Cervical infection with human papillomavirus type 16 (HR-HPV 16) is a key risk factor for cervical intraepithelial neoplasia and a sexually transmitted disease. The most significant cause of cervical cancer is the human p...
Report ID: 2044 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
The Neostigmine Methylsulfate Injection Market Size is valued at USD 156.54 Mn in 2022 and is predicted to reach USD 228.43 Mn by the year 2031 at a 4.4% CAGR during the forecast period for 2023-2031. Neostigmine methylsulfate is a reversible cholinesterase inhibitor. Cholinesterases are enzymes responsible for breaking down the neurotransmitter acetylcholine at the neuromuscular junction. By inhibiting these enzymes, neostigmine allows acetyl...
Report ID: 2046 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 175
The Mini Bioreactors and Micro Bioreactors Market is expected to grow at a 11.0 % CAGR during the forecast period for 2023-2031. Traditional methods for growing microbial cells have lagged behind automated technologies based on arrays for manipulating DNA and uncovering biological systems. Systems that enable optimization, quick testing, and bioprocess development in low volume, parallel research with setup, and in a short amount of time are t...
Report ID: 1295 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 170
The Nano-Dentistry Market Size is valued at 835.0 Million in 2022 and is predicted to reach 2739.0 Million by the year 2031 at a 14.2% CAGR during the forecast period for 2023-2031. The use of nanotechnology in dentistry for the detection, treatment and prevention of oral and dental disease is known as nano dentistry. These methods are meant to improve and preserve oral health. Nanotechnology, biotechnology, counting tissue design, and eventua...
Report ID: 1315 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 175
The Single-use Upstream Bioprocessing Market is expected to grow at a 15.7 % CAGR during the forecast period for 2023-2031. The first step in the bioprocess is upstream bioprocessing, which is used to generate cell lines and cultivate them in order to grow the cells by harvesting. Modern cell growth techniques produce bioreactors with noticeably higher titers, shorter time constraints, and more precision. Upstream manufacturing's main objectiv...
Report ID: 1318 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 180
Pharmaceuticals